English Deutsch 中文
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
Menu Deutsch 中文

CFDA Clears the Path for Early Integration of Global Clinical Trials in China

Mar. 15, 2017

The CFDA has issued draft guidelines in mid-March that would allow foreign pharma companies to run Phase I trials in China in the context of their global development, for the first time. This draft also proposes the removal of the existing requirement for local drug applications to be locally manufactured.